An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
Upcoming Clinical Trials
-
Memorial Sloan Kettering Cancer CenterNational Comprehensive Cancer Network; Syntrix PharmaceuticalsRecruitingLeptomeningeal Disease (LMD)United States
-
Johann Wolfgang Goethe University HospitalWuerzburg University HospitalNot yet recruitingAnemia | Pregnancy | Iron Deficiency Anaemia in ChildbirthGermany
-
George Eastman Dental Hospital, ItalyNot yet recruitingPeri-Implantitis and Peri-implant Mucositis
-
Incyte CorporationNot yet recruiting
-
Eli Lilly and CompanyNot yet recruiting
-
University of BaghdadNot yet recruitingRestless Leg Syndrome (RLS)Iraq
-
First Affiliated Hospital of Kunming Medical UniversityRecruitingInflammatory Bowel Disease | Ulcerative Colitis (UC)China
-
Emory UniversityNational Philanthropic Trust (NPT)Not yet recruitingInfluenzaUnited States
-
FIDAM RDCRoche Diabetes CareRecruitingDiabetes Mellitus | Diabetes Mellitus Type 2 | Sleep Quality | Ecological Momentary Assessment | Continuous Glucose Monitoring System | Diabetes (DM) | Diabetes Distress | Fear of Hypoglycemia | Diabetes Mellitus Type 1 | Glycemic Responses | Glycemic Variability | Diabetes Mellitus ( Type 1 and Type 2) | Predi... and other conditionsGermany
-
Florida Institute for Human and Machine CognitionApplied CognitionNot yet recruitingParkinson Disease (PD)
-
AUVA General Trauma Hospital SalzburgParacelsus Medical University; Salzburger LandesklinikenRecruiting